1. Home
  2. DFIN vs CDNA Comparison

DFIN vs CDNA Comparison

Compare DFIN & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Donnelley Financial Solutions Inc.

DFIN

Donnelley Financial Solutions Inc.

HOLD

Current Price

$50.03

Market Cap

1.2B

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$19.10

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DFIN
CDNA
Founded
1983
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
DFIN
CDNA
Price
$50.03
$19.10
Analyst Decision
Strong Buy
Buy
Analyst Count
2
7
Target Price
$63.50
$26.67
AVG Volume (30 Days)
276.4K
695.3K
Earning Date
02-17-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.12
1.22
Revenue
$750,800,000.00
$357,998,000.00
Revenue This Year
N/A
$14.11
Revenue Next Year
$4.20
$11.75
P/E Ratio
$42.49
$16.30
Revenue Growth
N/A
14.46
52 Week Low
$37.80
$10.96
52 Week High
$69.93
$25.95

Technical Indicators

Market Signals
Indicator
DFIN
CDNA
Relative Strength Index (RSI) 64.29 51.15
Support Level $44.89 $18.75
Resistance Level $47.86 $20.13
Average True Range (ATR) 1.45 0.77
MACD 0.38 -0.19
Stochastic Oscillator 98.85 51.61

Price Performance

Historical Comparison
DFIN
CDNA

About DFIN Donnelley Financial Solutions Inc.

Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: